H.L.M. Brus

760 total citations
18 papers, 594 citations indexed

About

H.L.M. Brus is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, H.L.M. Brus has authored 18 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 7 papers in Hematology and 2 papers in Genetics. Recurrent topics in H.L.M. Brus's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). H.L.M. Brus is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). H.L.M. Brus collaborates with scholars based in Netherlands and United States. H.L.M. Brus's co-authors include M.A.F.J. van de Laar, H. H. Kuper, Wietske Kievit, Tim Jansen, Jaap Fransen, Johannes J. Rasker, Erik Taal, O. Wiegman, Eddy Adang and Piet L. C. M. van Riel and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Patient Education and Counseling.

In The Last Decade

H.L.M. Brus

18 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.L.M. Brus Netherlands 10 471 189 111 102 78 18 594
S. Florentinus United States 13 364 0.8× 174 0.9× 107 1.0× 107 1.0× 47 0.6× 36 527
Dannette S. Johnson United States 11 529 1.1× 104 0.6× 129 1.2× 85 0.8× 162 2.1× 12 784
Anne‐Barbara Mongey United States 12 274 0.6× 65 0.3× 92 0.8× 67 0.7× 58 0.7× 21 455
Stefan Kleinert Germany 14 323 0.7× 138 0.7× 174 1.6× 43 0.4× 89 1.1× 52 591
Namita Tundia United States 14 231 0.5× 106 0.6× 69 0.6× 48 0.5× 37 0.5× 40 621
D Hofman Netherlands 4 499 1.1× 207 1.1× 61 0.5× 75 0.7× 73 0.9× 4 544
D. Tin Canada 15 592 1.3× 194 1.0× 95 0.9× 122 1.2× 110 1.4× 59 731
J Devlin United Kingdom 8 571 1.2× 190 1.0× 81 0.7× 49 0.5× 105 1.3× 13 875
Angela Nagel Germany 11 194 0.4× 51 0.3× 92 0.8× 174 1.7× 239 3.1× 28 528
Almut Scherer Switzerland 20 1.0k 2.2× 344 1.8× 524 4.7× 122 1.2× 86 1.1× 53 1.2k

Countries citing papers authored by H.L.M. Brus

Since Specialization
Citations

This map shows the geographic impact of H.L.M. Brus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.L.M. Brus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.L.M. Brus more than expected).

Fields of papers citing papers by H.L.M. Brus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.L.M. Brus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.L.M. Brus. The network helps show where H.L.M. Brus may publish in the future.

Co-authorship network of co-authors of H.L.M. Brus

This figure shows the co-authorship network connecting the top 25 collaborators of H.L.M. Brus. A scholar is included among the top collaborators of H.L.M. Brus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.L.M. Brus. H.L.M. Brus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Vermeer, M., A. E. van der Bijl, Marcel D. Posthumus, et al.. (2012). The new ACR / EULAR Definition of Remission in Rheumatoid Arthritis: Is the Patient Global Assessment Criterion too strict?. Annals of the Rheumatic Diseases. 70. 178. 4 indexed citations
3.
Vermeer, Maarten H., H. H. Kuper, A. E. van der Bijl, et al.. (2012). The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion. Lara D. Veeken. 51(6). 1076–1080. 45 indexed citations
4.
Kievit, Wietske, et al.. (2012). SAT0481 Are TNF blocking agents associated with changes in work participation in patients with RA?. Annals of the Rheumatic Diseases. 71. 635–635. 2 indexed citations
5.
6.
Kievit, Wietske, H. H. Kuper, Tim Jansen, et al.. (2010). Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice. Arthritis Care & Research. 62(9). 1335–1341. 32 indexed citations
7.
Kievit, Wietske, Jaap Fransen, Eddy Adang, et al.. (2008). Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. Annals of the Rheumatic Diseases. 68(6). 844–849. 13 indexed citations
8.
Kievit, Wietske, Eddy Adang, Jaap Fransen, et al.. (2008). The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Annals of the Rheumatic Diseases. 67(9). 1229–1234. 91 indexed citations
9.
Kievit, Wietske, Jaap Fransen, Anke Oerlemans, et al.. (2007). The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Annals of the Rheumatic Diseases. 66(11). 1473–1478. 146 indexed citations
10.
Kievit, Wietske, M.C.W. Creemers, Jaap Fransen, et al.. (2006). A higher rate of serious infections in patients treated with TNF blocking agents. University of Twente Research Information. 2 indexed citations
11.
Jaarsveld, Cornelia H.M. van, Johannes W G Jacobs, M. J. Van Der Veen, et al.. (2000). Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. Annals of the Rheumatic Diseases. 59(6). 468–477. 69 indexed citations
12.
Jaarsveld, Cornelia H.M. van, Z N Jahangier, J. W. G. Jacobs, et al.. (2000). Toxicity of anti‐rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Lara D. Veeken. 39(12). 1374–1382. 34 indexed citations
13.
Brus, H.L.M., M.A.F.J. van de Laar, Erik Taal, Johannes J. Rasker, & O. Wiegman. (1998). Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Annals of the Rheumatic Diseases. 57(3). 146–151. 107 indexed citations
14.
Jaarsveld, Cornelia H.M. van, Henny G. Otten, J. W. G. Jacobs, et al.. (1998). Is there an indication for HLA-DR typing for individual patients with rheumatoid arthritis?. PubMed. 16(4). 483–8. 10 indexed citations
15.
Brus, H.L.M., Johannes J. Rasker, O. Wiegman, Erik Taal, & Mart A F J van de Laar. (1995). Patient education improves compliance in early RA with active disease starting Sulphasalazine. University of Twente Research Information. 1 indexed citations
16.
Taal, Erik, et al.. (1994). Group self-management training for patients with rheumatoid arthritis. Data Archiving and Networked Services (DANS). 112–120. 1 indexed citations
17.
Taal, Erik, et al.. (1993). Group education for patients with rheumatoid arthritis. Patient Education and Counseling. 20(2-3). 177–187. 1 indexed citations
18.
Taal, Erik, et al.. (1992). Omgaan met reumatoide arthritis: Ontwikkeling en evaluatie van een groepsprogramma voor patiënten met reumatoide arthritis. Eindrapport projekt Patiëntenvoorlichting: De ontwikkeling van interventiemodellen voor de thuiszorg van patiënten. University of Twente Research Information. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Florentinus Breakdown of academic impact, for papers by Dannette S. Johnson Breakdown of academic impact, for papers by Anne‐Barbara Mongey Breakdown of academic impact, for papers by Stefan Kleinert Breakdown of academic impact, for papers by Namita Tundia Breakdown of academic impact, for papers by D Hofman Breakdown of academic impact, for papers by D. Tin Breakdown of academic impact, for papers by J Devlin Breakdown of academic impact, for papers by Angela Nagel Breakdown of academic impact, for papers by Almut Scherer
Rankless by CCL
2026